Suppr超能文献

Brain region-specific changes in N-acylethanolamine contents with time of day.

作者信息

Liedhegner Elizabeth Sabens, Sasman Amy, Hillard Cecilia J

机构信息

Neuroscience Research Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

出版信息

J Neurochem. 2014 Feb;128(4):491-506. doi: 10.1111/jnc.12495. Epub 2013 Nov 13.

Abstract

The N-acylethanolamines (NAEs) exert important behavioral, physiological, and immunological effects through actions at cannabinoid and other receptors. We measured concentrations of three NAEs, the Km and Vmax for fatty acid amide hydrolysis (FAAH), FAAH protein and FAAH mRNA in prefrontal cortex, hippocampus, hypothalamus, amygdala, striatum, and cerebellum at 4 h intervals, starting at 03:00. Significant differences in N-arachidonylethanolamine contents among the times examined occur in the prefrontal cortex (PFC), hippocampus, hypothalamus, and striatum. N-Oleoylethanolamine concentrations exhibit large fluctuations over the day in the cerebellum, including a threefold decrease between 19:00 and 23:00. N-Palmitoylethanolamine and N-oleoylethanolamine were significantly, positively correlated in all regions examined except the hypothalamus. FAAH Km values are significantly affected by time of day in PFC, hippocampus and amygdala and FAAH Vmax values are significantly affected in PFC, hippocampus and cerebellum. However, correlational data indicate that FAAH does not play a primary role in the circadian regulation of the NAE concentrations. FAAH protein expression is not significantly different among the harvest times in any brain region examined. Concentrations of 2-arachidonoylglycerol are significantly affected by time of harvest in the striatum and cerebellum, but not in other brain regions. Together, these data indicate that the NAEs exhibit diverse patterns of change with time of day that are likely the result of alterations in biosynthesis, and support the hypothesis that N-arachidonylethanolamine is a tonic activator of cannabinoid receptor signaling.

摘要

相似文献

1
Brain region-specific changes in N-acylethanolamine contents with time of day.
J Neurochem. 2014 Feb;128(4):491-506. doi: 10.1111/jnc.12495. Epub 2013 Nov 13.
3
Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period.
Synapse. 2013 Jan;67(1):4-10. doi: 10.1002/syn.21609. Epub 2012 Oct 4.
6
N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 May;1862(5):474-484. doi: 10.1016/j.bbalip.2017.01.001. Epub 2017 Jan 6.
7
Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.
J Biol Chem. 2010 Jan 22;285(4):2796-806. doi: 10.1074/jbc.M109.058461. Epub 2009 Nov 19.
8
Lipid profiling reveals tissue-specific differences for ethanolamide lipids in mice lacking fatty acid amide hydrolase.
Lipids. 2010 Sep;45(9):863-75. doi: 10.1007/s11745-010-3457-5. Epub 2010 Aug 17.
9
N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Prog Lipid Res. 2010 Oct;49(4):299-315. doi: 10.1016/j.plipres.2010.02.003. Epub 2010 Feb 10.

引用本文的文献

1
Systematic review/meta-analysis on the role of CB1R regulation in sleep-wake cycle in rats.
J Evid Based Med. 2024 Dec;17(4):714-728. doi: 10.1111/jebm.12643. Epub 2024 Sep 26.
2
Astrocyte Circadian Timekeeping in Brain Health and Neurodegeneration.
Adv Exp Med Biol. 2021;1344:87-110. doi: 10.1007/978-3-030-81147-1_6.
3
Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment.
Front Neurosci. 2020 Apr 21;14:371. doi: 10.3389/fnins.2020.00371. eCollection 2020.
4
Cannabinoid Signaling Recruits Astrocytes to Modulate Presynaptic Function in the Suprachiasmatic Nucleus.
eNeuro. 2020 Feb 13;7(1). doi: 10.1523/ENEURO.0081-19.2020. Print 2020 Jan/Feb.
5
Diurnal Profiles of -Acylethanolamines in Goldfish Brain and Gastrointestinal Tract: Possible Role of Feeding.
Front Neurosci. 2019 May 7;13:450. doi: 10.3389/fnins.2019.00450. eCollection 2019.
7
The Role of the Endocannabinoid System in the Brain-Gut Axis.
Gastroenterology. 2016 Aug;151(2):252-66. doi: 10.1053/j.gastro.2016.04.015. Epub 2016 Apr 29.
8
Endocannabinoid Signaling Regulates Sleep Stability.
PLoS One. 2016 Mar 31;11(3):e0152473. doi: 10.1371/journal.pone.0152473. eCollection 2016.
9
Endocannabinoids and the Endocrine System in Health and Disease.
Handb Exp Pharmacol. 2015;231:317-39. doi: 10.1007/978-3-319-20825-1_11.
10
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
J Neurosci. 2015 Jul 8;35(27):10039-57. doi: 10.1523/JNEUROSCI.4112-14.2015.

本文引用的文献

1
Brain structure predicts risk for obesity.
Appetite. 2012 Dec;59(3):859-65. doi: 10.1016/j.appet.2012.08.027. Epub 2012 Sep 7.
2
Endocannabinoids mediate the glucocorticoid-induced inhibition of excitatory synaptic transmission to dorsal raphe serotonin neurons.
J Physiol. 2012 Nov 15;590(22):5795-808. doi: 10.1113/jphysiol.2012.238659. Epub 2012 Sep 3.
3
Enzymological studies on the biosynthesis of N-acylethanolamines.
Biochim Biophys Acta. 2010 Dec;1801(12):1274-85. doi: 10.1016/j.bbalip.2010.08.010. Epub 2010 Aug 21.
4
Endocannabinoid signalling: has it got rhythm?
Br J Pharmacol. 2010 Jun;160(3):530-43. doi: 10.1111/j.1476-5381.2010.00790.x.
5
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.
Br J Pharmacol. 2010 Jun;160(3):423-42. doi: 10.1111/j.1476-5381.2010.00787.x.
7
Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.
Exp Neurol. 2010 Jul;224(1):48-55. doi: 10.1016/j.expneurol.2010.03.022. Epub 2010 Mar 29.
8
N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Prog Lipid Res. 2010 Oct;49(4):299-315. doi: 10.1016/j.plipres.2010.02.003. Epub 2010 Feb 10.
9
The endocannabinoid system and the treatment of mood and anxiety disorders.
CNS Neurol Disord Drug Targets. 2009 Dec;8(6):451-8. doi: 10.2174/187152709789824624.
10
Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.
Neuropsychopharmacology. 2009 Dec;34(13):2733-45. doi: 10.1038/npp.2009.114. Epub 2009 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验